Drug Delivery 2 (SIG)

Timeslot: Thursday, April 28, 2022 - 10:30am to 12:00pm
Room: Harborside Ballroom D-E


The Drug Delivery SIG session will consider abstracts that fall with the broad areas of therapeutic development, formulation, and application testing. Drug delivery from medical devices, tissue engineering scaffolds/hydrogels, films, microparticles, nanoparticles, environmentally responsive materials, and other types of biomaterial assemblies are all invited. Studies testing drug targeting, drug combinations, and drug/cell combinations are all also welcomed to submit. Drug delivery application areas of interest include but are not limited to regenerative medicine/tissue engineering, cell and tissue transplant, cardiovascular stents and other devices, cancer, microbial infection, and autoimmune diseases.


Abstracts will be available for download on April 27, 2022.

  • 10:30:00 AM 140. Uricase Functionalized Hydrogel for the Localized Treatment of Gout, Benjamin Keselowsky, PhD, Gregory Hudalla, PhD, Madeline Fuchs, Ryan Clark*; University of Florida, Gainesville, FL, USA

  • 10:45:00 AM 141. Semi-Randomized Zwitterionic Peptides to Prevent Nanoparticle Fouling, Clyde Overby, III(1,2)*, Danielle Benoit, Ph.D.(1,2); (1)University of Rochester, Rochester, NY, USA, (2)University of Rochester Medical Center, Rochester, NY, USA

  • 11:00:00 AM 142. Combination Nanomedicines for Acute Leukemia, Erik Dreaden, PhD*, Emory School of Medicine, Georgia Institute of Technology, Children’s Healthcare of Atlanta, Atlanta, GA, USA

  • 11:15:00 AM 143. Payload Capacity and Distribution of mRNA Lipid Nanoparticles, Yizong Hu*, Sixuan Li, Jinghan Lin, Tzahuei Wang, Hai-Quan Mao, Johns Hopkins University, Baltimore, MD, USA

  • 11:30:00 AM 144. Rational Design of Anti-Inflammatory Lipid Nanoparticles for mRNA Delivery, Drew Weissman, Hanwen Zhang, Xuexiang Han, Michael Mitchell*; University of Pennsylvania, Philadelphia, PA, USA

  • 11:45:00 AM 145. Orthogonal Modes of Immunomodulatory Protein Release from Injectable Liposomal Nanocomposite Hydrogels, Santiago Correa, PhD*, Abigail Grosskopf, John Klich, Eric Appel, PhD, Stanford, Stanford, CA, USA